[123I]MNI-672

N/A

Report date: 2025/12/01 17:16:47
NME

Base Information

Drug Name[123I]MNI-672
Drug Alias Name[123I]MNI-672
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 123I +[5] 
Mechanisms of ActionSingle-photon emission-computed tomography enhancersAmyloid binders
TargetsAmyloid
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInvicro Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Neuroimaging LlcInvicro Llc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A